UniSa - IRIS Institutional Research Information System

AMBONI, Marianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.360
NA - Nord America 9.243
EU - Europa 3.628
SA - Sud America 1.061
Continente sconosciuto - Info sul continente non disponibili 422
AF - Africa 121
OC - Oceania 57
Totale 27.892
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 9.098
US - Stati Uniti d'America 8.978
SG - Singapore 1.847
IT - Italia 1.406
CN - Cina 856
BR - Brasile 805
VN - Vietnam 669
RU - Federazione Russa 412
UA - Ucraina 355
DE - Germania 332
IE - Irlanda 224
FR - Francia 201
TR - Turchia 199
KR - Corea 162
SE - Svezia 158
GB - Regno Unito 156
CA - Canada 124
BD - Bangladesh 122
EE - Estonia 109
AR - Argentina 100
IN - India 99
FI - Finlandia 75
JP - Giappone 56
MX - Messico 53
EC - Ecuador 43
IQ - Iraq 41
PL - Polonia 38
ID - Indonesia 35
NL - Olanda 33
ZA - Sudafrica 33
PK - Pakistan 32
AU - Australia 31
CO - Colombia 30
ES - Italia 27
VE - Venezuela 27
NZ - Nuova Zelanda 24
JM - Giamaica 21
UZ - Uzbekistan 21
CZ - Repubblica Ceca 19
CL - Cile 17
PY - Paraguay 17
AT - Austria 16
KE - Kenya 16
MA - Marocco 16
MY - Malesia 13
SA - Arabia Saudita 12
TN - Tunisia 11
CR - Costa Rica 10
DZ - Algeria 10
PH - Filippine 10
AZ - Azerbaigian 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GT - Guatemala 8
IL - Israele 8
JO - Giordania 8
AL - Albania 7
BA - Bosnia-Erzegovina 7
HN - Honduras 7
LB - Libano 7
LT - Lituania 7
OM - Oman 7
CH - Svizzera 6
EG - Egitto 6
KZ - Kazakistan 6
NI - Nicaragua 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
BO - Bolivia 5
EU - Europa 5
PR - Porto Rico 5
SV - El Salvador 5
BY - Bielorussia 4
HR - Croazia 4
SN - Senegal 4
BB - Barbados 3
BH - Bahrain 3
BS - Bahamas 3
CI - Costa d'Avorio 3
LY - Libia 3
MD - Moldavia 3
ME - Montenegro 3
MN - Mongolia 3
PA - Panama 3
RS - Serbia 3
TH - Thailandia 3
BW - Botswana 2
CY - Cipro 2
DK - Danimarca 2
DM - Dominica 2
IR - Iran 2
KH - Cambogia 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MM - Myanmar 2
PS - Palestinian Territory 2
Totale 27.441
Salva come PNG Salva come JPEG
Città #
Hong Kong 9.080
San Jose 1.194
Ann Arbor 1.105
Singapore 884
Milan 581
Princeton 519
Ashburn 518
Chandler 510
Wilmington 473
Dallas 453
Jacksonville 434
Council Bluffs 378
Houston 264
Beijing 216
Dublin 210
Woodbridge 201
Izmir 166
Ho Chi Minh City 165
The Dalles 160
Rome 159
Lauterbourg 155
Dong Ket 136
New York 134
Los Angeles 132
Hanoi 131
Nanjing 112
Moscow 111
Tallinn 107
Andover 104
Santa Clara 102
Boardman 86
Salerno 74
São Paulo 74
Munich 65
Pellezzano 64
Naples 56
Düsseldorf 55
Norwalk 53
Figino 50
Phoenix 48
Buffalo 45
Dearborn 44
Shenyang 43
Nanchang 39
Tokyo 39
San Francisco 38
Chicago 37
Fairfield 34
Mestre 34
Montreal 33
Haiphong 31
Denver 29
Frankfurt am Main 29
Hebei 29
Rio de Janeiro 29
Warsaw 29
Atlanta 28
Brooklyn 28
Memphis 27
Redwood City 26
Jiaxing 25
Da Nang 24
Orem 24
Nuremberg 23
Turin 23
Chennai 22
Changsha 21
London 21
Pune 21
Amsterdam 20
Mexico City 20
Boston 19
San Diego 19
Seattle 19
Tashkent 19
Philadelphia 18
Tianjin 18
Washington 18
Baghdad 17
Bologna 16
Poplar 16
Belo Horizonte 15
Guarulhos 15
Nairobi 15
Stockholm 15
Ankara 14
Brasília 14
Casoria 14
Curitiba 14
Porto Alegre 14
Quito 14
Shanghai 14
Toronto 14
Biên Hòa 13
Columbus 13
Guangzhou 13
Kingston 13
Las Vegas 13
Seoul 13
Turku 13
Totale 20.876
Salva come PNG Salva come JPEG
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 1.011
Sex Differences in Parkinson’s Disease: From Bench to Bedside 657
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 626
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 610
Gender differences in microRNA expression in levodopa-naive PD patients 585
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 553
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 551
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 541
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 525
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 446
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 431
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 413
The most effective way to obtain long-term memory is to increase first presentation duration of single words 382
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 343
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 338
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 308
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 295
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 285
Classifying Different Stages of Parkinson’s Disease Through Random Forests 277
Metabolomics in Parkinson's disease 270
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 267
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 255
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 229
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 223
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 219
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 217
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 208
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 205
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 203
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 198
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 193
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 192
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 188
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 187
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 177
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 176
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 171
Quitting smoking: An early non-motor feature of Parkinson's disease? 170
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 169
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 167
Abnormal eating behaviors in progressive supranuclear palsy. 167
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 165
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 165
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 163
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 161
Machine learning can predict mild cognitive impairment in Parkinson's disease 159
Increased bilirubin levels in de novo Parkinson's disease 157
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 154
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 154
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 153
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 149
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 146
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 146
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 145
Bisphenol A glucuronidation in patients with Parkinson's disease 143
Clinical and neurological abnormalities in adult celiac disease. 143
Cognitive correlates of “pure apathy” in Parkinson's disease 143
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 141
Freezing of gait and executive functions in patients with Parkinson’s disease 141
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 139
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 137
Gender and non motor fluctuations in Parkinson's disease: A prospective study 134
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 133
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 131
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 129
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 126
“Response to Apomorphine in early Parkinson’s disease”. 126
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 125
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 124
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 124
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 123
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 123
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 121
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 120
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 119
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 118
Parkinson’s disease and the spectrum of Lewy body disease 118
Uric acid relates to dopamine transporter availability in Parkinson's disease. 117
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 117
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 117
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 117
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 116
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 116
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 116
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 115
Gait patterns and cognition in Parkinson's disease 115
Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy 114
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 110
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance ofPARK2: an FP-CIT SPECT study 108
Cognitive contributions to gait and falls: Evidence and implications 108
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 107
Performing a short sway to distinguish Parkinsonisms 107
The "eye of the tiger" sign in pure akinesia with gait freezing. 107
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 106
Development of software tool for quantitative gait assessment in Parkinsonian patients with and without Mild Cognitive Impairment 106
Motor, cognitive and behavioral differences in MDS PSP phenotypes 105
Exercise dependence induced by pramipexole in Parkinson's Disease-a case report. 104
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 104
Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson's disease 103
Resting brain networks in patients with Parkinson's disease and freezing of gait 103
Totale 21.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022806 0 0 0 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202616.449 1.587 4.538 3.992 682 920 437 1.312 305 431 884 248 1.113
2026/20271.782 496 239 716 331 0 0 0 0 0 0 0 0
Totale 27.892